TP53 and neoplasm: The median age of tumour onset in the index cases of 17 years is lesser than that described previously [15] Multiple cancers and therapy-related malignancies have been reported in previous studies, with Mai et al [4] describing 49% of germline TP53 mutation carriers who had second malignancies after a median period of 10 years.